Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review
about
sameAs
Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditionsExperience with Subgam, a Subcutaneously Administered Human Normal Immunoglobulin (ClinicalTrials.gov--NCT02247141)Update on the hyper immunoglobulin M syndromesIdentifying functional anti-Staphylococcus aureus antibodies by sequencing antibody repertoires of patient plasmablasts.Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement.Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency.Calculated globulin (CG) as a screening test for antibody deficiency.Quality of life in children with primary antibody deficiency.Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice.Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections.Immune deficiency: changing spectrum of pathogens.Human normal immunoglobulin in the treatment of primary immunodeficiency diseases.Recurrent myelitis in common variable immunodeficiency successfully managed with high-dose subcutaneous immunoglobulin.Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration.Quantitative Evidence of Wear-Off Effect at the End of the Intravenous IgG (IVIG) Dosing Cycle in Primary Immunodeficiency.Family Physician Perspectives on Primary Immunodeficiency DiseasesHealth-Related Quality of Life and Health Resource Utilization in Patients with Primary Immunodeficiency Disease Prior to and Following 12 Months of Immunoglobulin G Treatment.Clinical immunology review series: an approach to the patient with recurrent infections in childhood.Clinical immunology review series: an approach to the patient with recurrent superficial abscesses.Possible primary immunodeficiency presenting with gastrointestinal symptoms: Case report and minireviewClinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency.Improving the evidence base for transfusion medicine: the work of the UK systematic review initiative.Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes.Attending to warning signs of primary immunodeficiency diseases across the range of clinical practiceCommon variable immunodeficiency (CVID): case report and review of the literature.Detection of pulmonary complications in common variable immunodeficiency.Diagnostic approach to primary immunodeficiency disorders.Pulmonary manifestations of primary immunodeficiency disorders in childrenPharmacokinetics, Safety, and Tolerability of Subcutaneous Immune Globulin Injection (Human), 10 % Caprylate/Chromatography Purified (GAMUNEX®-C) in Pediatric Patients with Primary Immunodeficiency Disease.Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery.Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation.Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient?A cohort of French pediatric patients with primary immunodeficiencies: are patient preferences regarding replacement immunotherapy fulfilled in real-life conditions?Clinical and imaging considerations in primary immunodeficiency disorders: an update.Clinical experiences in primary and secondary immunodeficiencies and immune-mediated conditions using Gammanorm(®).Efficacy and safety of Gammaplex(®) 5% in children and adolescents with primary immunodeficiency diseases.Gastrointestinal disorders next to respiratory infections as leading symptoms of X-linked agammaglobulinemia in children - 34-year experience of a single center.Efficacy and safety of a new immunoglobulin G product, Gammaplex(®), in primary immunodeficiency diseases.Antibody deficiency in Rubinstein-Taybi syndrome.Primary Immunodeficiency Diseases: An Opportunity in Pediatrics for Improving Patient Outcomes.
P2860
Q28240370-ABFA719D-C94C-48F9-B23D-8836767D8609Q28546873-05693098-25D1-40B4-84F1-2CE9CE25B3D2Q28972255-C3330B14-A708-48CB-BA8D-965CB0E524B0Q33788094-5A66CE47-8CF5-488C-A144-DAAFAAF6222DQ33817252-5D02FC08-68EC-496B-9418-0CFD711D396EQ33843992-B3FEE109-BD1B-4121-9F46-C16AB9B67A62Q34065381-5EDB13D3-3DFB-4E8B-B7DF-207F9B96F6FDQ34196126-6F886D88-33B5-4401-8F73-53C958B4A085Q34478033-F43218D5-BC96-4BBA-AC98-B5A4827E9CB3Q34992090-415AE421-530D-4499-A4DE-CCF7F2F477A5Q35893163-0BE1E340-77B7-40FB-B1C7-459A08D9AF44Q35905557-467BA1BB-C482-4472-8308-3F4E3889EF1CQ35975877-C0273F67-6029-4DE8-B063-47C5B75A0B57Q35979722-6AABED1C-AA02-4CD6-914A-95ADD24D0567Q36688462-6613CB30-3107-4193-A0A4-E30288D44266Q36740401-C924AC21-50D8-4E4A-AFE4-77471714F048Q36978846-7DDC0B30-22BB-40EE-9314-263C7339CDB3Q37121906-CB7D9942-3E97-4616-8E98-3D38FE82EF22Q37142181-792DBB22-BAAD-4D2C-805D-A6BEFD740BBFQ37207168-2EEE8238-BB54-4F44-85E8-462E0AE4ED8DQ37364113-3BE65D2F-C8B1-40CA-9576-735B306BBDD5Q37423362-73F35ACD-9996-4060-9399-702EECBC4FE1Q37441210-D815F84D-C6CE-4DD4-B896-9724FA3F3FCDQ37595906-0676166F-56B1-4305-8B97-8122B4C868B0Q37610116-259B64E3-BA9D-4C46-8BBE-8001398E8742Q37632587-75F9CC32-81A1-41C8-91A5-E7EBE50F796DQ38128689-24FED2CB-8024-4F67-AE78-9B2A736265A5Q38239698-617EFC9A-B243-4E26-AED2-E566AD3BBD25Q38390889-797735D6-6B03-4ED3-9818-07275382421AQ38398798-03AA4CA8-C903-4002-B54D-E6CC3CAA9905Q38420971-CE111409-0999-4ADE-8584-7FE0EC3779C3Q38569717-F98EEA72-6CE3-4B04-9FB2-D82BFB211C2DQ38661420-4554A7CA-F565-4716-9C00-03ED61DF93C8Q38961320-CD2E6CFB-7889-47E0-92B4-72D95A4BFCF2Q39217483-190F6970-FD35-45F3-88BA-0EEE347B5BE7Q40179168-E5A9876F-8A58-42B2-BEA1-5F31E36A0F38Q40307695-ACB15E18-A068-456D-9571-65F7EE1C084BQ40343724-9AAD87D7-83FE-4312-9F08-F08675B60677Q41033457-1706279E-9EAA-4F6C-AF58-0DE9A5F0D3B1Q41205852-558B96B6-4803-4C84-BB83-5E0899D31A80
P2860
Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Recognition, clinical diagnosi ...... iciencies: a systematic review
@ast
Recognition, clinical diagnosi ...... iciencies: a systematic review
@en
Recognition, clinical diagnosi ...... iciencies: a systematic review
@nl
type
label
Recognition, clinical diagnosi ...... iciencies: a systematic review
@ast
Recognition, clinical diagnosi ...... iciencies: a systematic review
@en
Recognition, clinical diagnosi ...... iciencies: a systematic review
@nl
prefLabel
Recognition, clinical diagnosi ...... iciencies: a systematic review
@ast
Recognition, clinical diagnosi ...... iciencies: a systematic review
@en
Recognition, clinical diagnosi ...... iciencies: a systematic review
@nl
P2093
P2860
P921
P3181
P1476
Recognition, clinical diagnosi ...... iciencies: a systematic review
@en
P2093
D G Peckham
S Stanworth
P2860
P304
P3181
P356
10.1111/J.1365-2249.2007.03432.X
P407
P577
2007-09-01T00:00:00Z